Penn Engineering Hosts “AI at the Crossroads: Ethics, Innovation & Impact” During Philly Tech Week
Melissa Kelly, PhD, Deputy Managing Director of PCI, served as a panelist and shared her insights on the impact of AI.
AI Across Disciplines Event Highlights Penn’s Role in Shaping AI
At a cross-disciplinary gathering at Amy Gutmann Hall, the Penn community celebrated the launch of the Penn AI Initiative with a panel discussing AI research at Penn.
Penn’s Jake Brenner Develops State-of-the-art DNA-Delivery Technology
By safely delivering therapeutic DNA to cells, this technology has the potential to transform treatment for common chronic diseases.
2025 President’s Innovation Prize Winner Announced
The team is developing a privacy-centric AI system to support eldercare by reducing staff burnout and addressing gaps in caregiving.
Veradermics Closes Series B Financing and Initiates Phase 2/3 Trial for Hair Loss
Veradermics is a late clinical-stage aesthetics and dermatology-focused biopharmaceutical company developing first-in-class therapeutics for common dermatologic conditions.
Vivodyne Weighs in on FDA Proposed Initiative
The FDA recently revealed a new initiative aimed at eliminating the need to test antibody therapeutics in animal models and replacing them with AI modelling or lab-grown human organoids.
Opus Genetics Celebrates Early Win for Retinal Gene Therapy in Pediatric Patient
According to the data, the 16-year-old patient, who was treated in February, showed "meaningful improvement in visual function."
Philadelphia Launches SBIR/STTR Matching Grant Program
Philadelphia has launched a new matching grant program to support local life sciences companies.
Greater Philadelphia Maintains #4 U.S. Life Sciences Market Rank in Colliers 2025 Report
The report recognizes the region’s strong VC funding environment, robust life sciences talent pool and growing life sciences real estate leasing activity.
Penn Researchers Help Develop Data-driven Map Showing Local Economic Impact of Cuts to Federal Funding for Health Research
The Science & Community Impacts Mapping Project (SCIMaP) aims to demonstrate how reduced investment in health research negatively affects both innovation and local economies.